Senior leadership team is strengthened to help
drive the connected nursery ecosystem platform and
telehealth-related growth opportunities
Owlet Baby Care Inc. (“Owlet” or the “Company”), the
connected nursery ecosystem that delivers data-driven technology to
modern parenting, is pleased to announce that it has appointed Jim
Fidacaro as Healthcare General Manager. The appointment of Fidacaro
further strengthens Owlet’s leadership team expansion as the
company continues to disrupt and transform the connected nursery
ecosystem of the future.
Fidacaro comes to Owlet as the Healthcare General Manager with
25 years of experience in the healthcare industry and a deep
background in digital healthcare and medical devices. Prior to
joining Owlet, Fidacaro drove Philips' strategic roadmap for
Healthcare Informatics and marketing operations for Connect Care,
following roles as Vice President, Marketing and Business
Development at ImaCor, and C.E.O. of Synsei Medical, an early-stage
wearable maternal and baby digital healthcare company, and an
executive at Mindray, as Dean of the Technology Research Institute.
Fidacaro’s innovation expertise extends to his as a holder of
numerous U.S. patents and several design awards.
“I met the Owlet team in their early stages, as I was leading
other digital healthcare platforms, and was very impressed with how
they live their mission to empower modern parenting worldwide with
the right insights at the right time,” says Jim Fidacaro, new
Healthcare General Manager at Owlet. “Today, more than 1.5 million
parents have put their trust in the Owlet brand, helping them
monitor over 850,000 babies with over four-trillion heartbeats
tracked. I am honored to join the Owlet family, a team that I
believe has a data set that could revolutionize healthcare in
pediatrics, and to accelerate the digital telehealth ecosystem and
Artificial Intelligence from parents to babies.”
Owlet expects Fidacaro’s healthcare experience to help catapult
the brand forward as Owlet seeks to position itself as a leader in
data-driven insights on infant health and telehealth. As an example
of the potential power of Owlet’s data set, a recent study reviewed
and approved by the Institutional Review Board at the Cleveland
Clinic and published in The Journal of Pediatrics found the
cumulative incidence of irregular heartbeat among infants using the
Owlet Smart Sock to be significantly higher than rates reported in
prior studies.
“I couldn’t be more confident in the future of Owlet with the
addition of Jim to help us expand Owlet as a connected nursery
ecosystem with the potential to enable data-driven telehealth at
home,” said Kurt Workman, CEO and founder of Owlet. “We believe the
Cleveland Clinic study is indicative of the types of meaningful
insights that we can observe from our products, and we are thrilled
to be able to leverage Jim’s deep knowledge of the healthcare
industry and innovation in healthcare products as we continue our
growth trajectory. Our goal is to bring modern parents increased
transparency and education about their children through our new and
forthcoming product and software services. Every parent deserves to
feel empowered during the journey of parenthood, and I know
bringing Jim on board will help get us closer to reaching even more
parents globally.”
For more information about Owlet Baby Care, please visit
https://owletcare.com/.
About Owlet Baby Care
Owlet Baby Care was founded by a team of parents in 2012.
Owlet’s mission is to empower parents with the right information at
the right time, to give them more peace of mind, and help them find
more joy in the journey of parenting. Owlet’s digital parenting
platform aims to give parents real-time data and insights to help
parents feel more calm and confident. Owlet believes that every
parent deserves peace of mind and the opportunity to feel their
well-rested best. Owlet also believes that every child deserves to
live a long, happy, and healthy life, and is working to develop
products to help facilitate that belief.
Additional Information and Where to Find It
In February, Owlet entered into a definitive merger agreement in
February with Sandbridge Acquisition Corporation (NYSE: SBG)
(“Sandbridge”), a special purpose acquisition company.
Sandbridge intends to file with the SEC a Registration Statement
on Form S-4, which will include a proxy statement/prospectus, that
will be both the proxy statement to be distributed to holders of
Sandbridge’s Class A common stock in connection with its
solicitation of proxies for the vote by Sandbridge’s stockholders
with respect to the business combination and other matters as may
be described in the registration statement, as well as the
prospectus relating to the offer and sale of certain securities to
be issued in the business combination. After the registration
statement is declared effective, Sandbridge will mail a definitive
proxy statement/prospectus and other relevant documents to its
stockholders. This press release does not contain all the
information that should be considered concerning the proposed
business combination and is not intended to form the basis of any
investment decision or any other decision in respect of the
proposed business combination. Sandbridge’s stockholders and other
interested persons are advised to read, when available, the
preliminary proxy statement/prospectus included in the registration
statement and the amendments thereto and the definitive proxy
statement/prospectus and other documents filed in connection with
the proposed business combination, as these materials will contain
important information about the Company, Sandbridge and the
proposed business combination. When available, the definitive proxy
statement/prospectus and other relevant materials for the proposed
business combination will be mailed to stockholders of Sandbridge
as of a record date to be established for voting on the proposed
business combination. Stockholders of Sandbridge will also be able
to obtain copies of the preliminary proxy statement, the definitive
proxy statement and other documents filed with the SEC, without
charge, once available, at the SEC’s website at www.sec.gov, or by
directing a written request to: Sandbridge Acquisition Corp., 1999
Avenue of the Stars, Suite 2088, Los Angeles, California 90067.
Participants in the Solicitation
Sandbridge and its directors and executive officers may be
deemed participants in the solicitation of proxies from
Sandbridge’s stockholders with respect to the proposed business
combination. The names of those directors and executive officers
and a description of their interests in Sandbridge is contained in
Sandbridge’s final prospectus dated September 14, 2020 relating to
its initial public offering and in subsequent filings with the SEC,
which are available free of charge at the SEC’s web site at
www.sec.gov. To the extent such holdings of Sandbridge’s securities
may have changed since that time, such changes have been or will be
reflected on Statements of Changes in Beneficial Ownership on Form
4 filed with the SEC. Additional information regarding the
interests of such participants will be contained in the proxy
statement/prospectus for the proposed business combination when
available.
Owlet and its directors and executive officers may also be
deemed to be participants in the solicitation of proxies from the
stockholders of Sandbridge in connection with the proposed business
combination. A list of the names of such directors and executive
officers and information regarding their interests in the proposed
business combination will be included in the proxy
statement/prospectus for the proposed business combination when
available.
Forward-Looking Statements
Certain statements, estimates, targets, and projections in this
press release may be considered forward-looking statements.
Forward-looking statements generally relate to future events or
Sandbridge’s or Owlet’s future financial or operating performance.
For example, statements regarding the expected future operating and
financial performance and market opportunities of Owlet are
forward-looking statements. In some cases, you can identify
forward-looking statements by terminology such as “may”, “should”,
“expect”, “intend”, “will”, “estimate”, “anticipate”, “believe”,
“predict”, “potential” or “continue”, or the negatives of these
terms or variations of them or similar terminology. Such
forward-looking statements are subject to risks, uncertainties, and
other factors which could cause actual results to differ materially
from those expressed or implied by such forward-looking
statements.
These forward-looking statements are based upon estimates and
assumptions that, while considered reasonable by Sandbridge and its
management, and Owlet and its management, as the case may be, are
inherently uncertain. Factors that may cause actual results to
differ materially from current expectations include, but are not
limited to: the occurrence of any event, change or other
circumstances that could give rise to the termination of any
definitive agreements with respect to the proposed business
combination; the outcome of any legal proceedings that may be
instituted against Sandbridge, Owlet, the combined company or
others following the announcement of the proposed business
combination and any definitive agreements with respect thereto; the
inability to complete the proposed business combination due to the
failure to obtain approval of the stockholders of Sandbridge or to
satisfy other conditions to closing, including the satisfaction of
the minimum trust account amount following any redemptions; changes
to the proposed structure or terms of the business combination that
may be required or appropriate as a result of applicable laws or
regulations or in response to market reaction to the announcement
of the transaction; the ability to meet stock exchange listing
standards at or following the consummation of the proposed business
combination; the risk that the proposed business combination
disrupts current plans and operations of Owlet as a result of the
announcement and consummation of the proposed business combination,
and as a result of the post-transaction company being a publicly
listed issuer; the ability to recognize the anticipated benefits of
the proposed business combination, which may be affected by, among
other things, competition, the regulatory pathway for Owlet
products and responses from regulators, including the U.S. Food and
Drug Administration and similar regulators outside of the United
States, the ability of the combined company to grow and manage
growth profitably, maintain relationships with customers and
suppliers and retain Owlet’s management and key employees; costs
related to the proposed business combination, including costs
associated with the post-transaction company being a publicly
listed issuer; changes in applicable laws or regulations; the
possibility that Owlet or the combined company may be adversely
affected by other economic, business, regulatory and/or competitive
factors; Owlet’s estimates of expenses and profitability; the
evolution of the markets in which Owlet competes; the ability of
Owlet to implement its strategic initiatives and continue to
innovate its existing products; the ability of Owlet to defend its
intellectual property and satisfy regulatory requirements; the
impact of the COVID 19 pandemic on Owlet’s business; the limited
operating history of Owlet; and other risks and uncertainties set
forth in the section entitled “Risk Factors” and “Cautionary Note
Regarding Forward-Looking Statements” in Sandbridge’s final
prospectus dated September 14, 2020 relating to its initial public
offering, and other risks and uncertainties indicated from time to
time in the definitive proxy statement to be delivered to
Sandbridge’s stockholders and the related registration statement on
Form S-4, including those set forth under “Risk Factors” therein,
and other documents to be filed with the SEC by Sandbridge.
Nothing in this press release should be regarded as a
representation by any person that the forward-looking statements
set forth herein will be achieved or that any of the contemplated
results of such forward-looking statements will be achieved. You
should not place undue reliance on forward-looking statements,
which speak only as of the date they are made. Neither Sandbridge
nor Owlet undertakes any duty to update these forward-looking
statements.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210309006068/en/
Investor Relations
Owlet Baby Care Constantine Davides Westwicke, an ICR company
constantine.davides@westwicke.com (339) 970-2846
Sandbridge Acquisition Corporation Rebecca Campbell Konnect
Agency rcampbell@konnectagency.com (213) 225-4415
Media Relations
Cammy Duong Westwicke, an ICR company cammy.duong@westwicke.com
(203) 682-8380
Sandbridge Acquisition Corporation Rebecca Campbell Konnect
Agency rcampbell@konnectagency.com (213) 225-4415
Sandbridge Aquisition (NYSE:SBG.U)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Sandbridge Aquisition (NYSE:SBG.U)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024